how many people use cryptocurrency, Reviews

An earthquake with a magnitude of 5.6 occurred in the sea area northeast of Fiji. According to the measurement of the European and Mediterranean Earthquake Center, at 13: 51 local time on December 12th, a magnitude of 5.6 earthquake occurred in the sea area 478 kilometers northeast of Suva, Fiji (15.201 degrees south latitude and 178.282 degrees west longitude) with a focal depth of 10 kilometers.China Seismological Network officially determined that an earthquake of magnitude 5.2 occurred in Fiji Islands (14.95 degrees south latitude and 178.15 degrees west longitude) at 09: 51 on December 12, with a focal depth of 10 kilometers.The negative spread of 10-year national debt between China and the United States has expanded to nearly 250BP, which is the largest in more than 22 years.

According to court documents, the US Department of Justice asked the court to reject ByteDance and TikTok's request to postpone the law banning applications before January 19.The next "explosion point" of biomedicine may appear in Shenzhen. "China's pharmaceutical innovation ranks first in the second echelon in the world in terms of the quantitative indicators of R&D pipelines and listed new drugs." A few days ago, Song Ruilin, executive president of China Pharmaceutical Innovation Promotion Association, held the "Star of the Bay Area" biomedical source innovation conference in Shenzhen, and believed that China's pharmaceutical research and industrial development were entering a new stage of innovation. Chen Qiyu, vice president of China Pharmaceutical Innovation Promotion Association and executive director and co-CEO of Fosun International, said that Shenzhen has great advantages and development momentum in linking Greater Bay Area's urban development and AI technology. By leveraging the resources in the Bay Area and making good use of these advantages, it is possible to find a new fulcrum in the future biomedical R&D innovation track, and the next "explosion point" of biomedicine is likely to appear in Shenzhen.Zhejiang has published a list of the top 500 enterprises. According to the news released by Zhejiang in WeChat official account, Zhejiang Institute of Science and Technology Information organized the evaluation of innovation ability of high-tech enterprises, and recently selected the top 500 high-tech enterprises in Zhejiang Province in 2024. Among them, Hangzhou Hikvision Digital Technology Co., Ltd., Ningbo Oaks Electric Co., Ltd. and Xinhua San Technology Co., Ltd. are in the top three.

Ministry of Human Resources and Social Security and other five departments: Since December 15th, the personal pension system has been pushed from 36 pilot cities (regions) to the whole country, and the Ministry of Human Resources and Social Security and other five departments have issued the Notice on the Full Implementation of the Personal Pension System. Since December 15th, the personal pension system has been extended from 36 pilot cities (regions) to the whole country. The so-called personal pension is a supplementary old-age insurance system with voluntary participation, market-oriented operation and national policy support. Individuals voluntarily deposit a sum of money in a specific account, which does not exceed 12,000 yuan per year. Different from ordinary bank wealth management, funds and commercial insurance, individual pensions can enjoy the preferential policy of deferred taxation. In order to promote the preservation and appreciation of individual pensions, the circular requires optimizing product supply, and on the basis of existing financial products such as wealth management products, savings deposits, commercial pension insurance and Public Offering of Fund, specific pension savings and index funds will be included in the catalogue of individual pension products. (Xinhua News Agency)The individual pension system has been extended to the whole country. (Xinhua News Agency)Genting Xinyao: The first prescription of itramod in Macau, China officially benefited Asian patients. Genting Xinyao announced that its first prescription of itramod was made in Jinghu Hospital in Macau, China on December 11th, which was the first prescription made by itramod after it was approved in Genting Xinyao Asia Authorized Zone, marking that this heavy product in the field of autoimmune diseases officially began to benefit Asian patients. Luo Yongqing, CEO of Genting Xinyao, said that the arrival of the first prescription of Ithmod in China and Macau was another milestone in the commercialization of Genting Xinyao. By 2030, the number of patients with ulcerative colitis in China is expected to more than double that in 2019, reaching about 1 million. There is a huge unmet demand for innovative therapies. Following the approval in Macau in April this year, Iturmod, as the third commercial new drug of Genting Xinyao, will bring new treatment options to more patients with ulcerative colitis.